首页> 外文期刊>Journal of cataract and refractive surgery >Visual and refractive results of combined PTK/PRK in patients with corneal surface disease and refractive errors.
【24h】

Visual and refractive results of combined PTK/PRK in patients with corneal surface disease and refractive errors.

机译:PTK / PRK联合治疗角膜表面疾病和屈光不正患者的视觉和屈光结果。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To investigate the changes in symptoms, refraction, and visual acuity (VA) in patients with corneal surface disease and refractive errors who had phototherapeutic keratectomy (PTK) combined with photorefractive keratectomy (PRK). SETTING: University-based referral practice. METHODS: Patients with myopia or astigmatism and map-dot-fingerprint dystrophy or recurrent erosions were treated. The corneal epithelium was removed with a 64 blade, and laser was performed using a Visx Star S3 laser. RESULTS: Nineteen eyes of 14 patients were treated. Preoperatively, mean myopia was -3.76 diopters (D) (range -7.50 to -0.75 D), mean astigmatism was +0.96 D (range 0.00 to +2.25 D), and mean UCVA was 20/400. At 3 months, mean myopia was -0.53 D (range -1.75 to +0.75 D) (P<.001), mean astigmatism was +0.58 D (range 0.00 to +1.25 D) (P = .05), and mean uncorrected VA was 20/23 (P<.001). At 6 months, mean myopia was -0.31 D (range -1.00 to +0.75 D) (P<.001), mean astigmatism was +0.56 D (range 0.00 to +1.25 D) (P = .05), and mean uncorrected VA was 20/23 (P<.001). The change in astigmatism was confirmed by vector analysis. Only 1 patient lost 1 line of acuity, and all patients were asymptomatic. CONCLUSION: Patients with myopia and astigmatism and symptomatic epithelial basement membrane disorders who had PTK/PRK had resolution of their symptoms and nearly achieved emmetropia. Therefore, this procedure is safe and effective for patients with corneal surface disease and myopia.
机译:目的:调查角膜表面疾病和屈光不正患者接受光疗性角膜切除术(PTK)联合光折光性角膜切除术(PRK)的症状,屈光和视敏度(VA)的变化。地点:基于大学的推荐实践。方法:对患有近视或散光,地图点状指纹营养不良或复发性糜烂的患者进行治疗。用64刀片除去角膜上皮,并使用Visx Star S3激光进行激光。结果:治疗14例患者的19只眼。术前平均近视为-3.76屈光度(D)(范围-7.50至-0.75 D),平均散光为+0.96 D(范围0.00至+2.25 D),平均UCVA为20/400。在3个月时,平均近视度为-0.53 D(范围-1.75至+0.75 D)(P <.001),平均散光为+0.58 D(范围0.00至+1.25 D)(P = .05)和未校正的平均值VA为20/23(P <.001)。在6个月时,平均近视度为-0.31 D(范围-1.00至+0.75 D)(P <.001),平均散光为+0.56 D(范围0.00至+1.25 D)(P = .05)和未校正的平均值VA为20/23(P <.001)。散光的变化通过载体分析得到证实。只有1例患者失去了1线视力,所有患者均无症状。结论:患有PTK / PRK的近视,散光和有症状的上皮基底膜疾病的患者症状可以缓解,正视眼几乎可以实现。因此,该方法对于患有角膜表面疾病和近视的患者是安全有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号